Taro Pharmaceutical Industries Ltd.
(NYSE: TARO)
Rigrodsky Law, P.A. is investigating Taro Pharmaceutical Industries Ltd. (“Taro”) regarding possible breaches of fiduciary duties and other violations of law related to Taro’s agreement to be acquired by Sun Pharmaceutical Industries Limited. Under the terms of the agreement, Taro shareholders will receive $43.00 per share in cash.